Lenalidomide consolidation and maintenance therapy after autologous stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis-Reference-Cited by-同舟云学术

Lenalidomide consolidation and maintenance therapy after autologous stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis

Published:2013-12-31 Issue:8 Volume:55 Page:1788-1795
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Clave Emmanuel,Douay Corinne,Coman Tereza,Busson Marc,Bompoint Caroline,Moins-Teisserenc Helene,Glauzy Salomé,Carmagnat Maryvonnick,Gorin Norbert Claude,Toubert Antoine,Garderet Laurent

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2013.865182

Reference43 articles.

1. Multiple myeloma: biology of the disease

2. Immunotherapy in multiple myeloma - possibility or probability?

3. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells

4. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

5. Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Cell and Immune Engagers in Optimizing Tumor- Specific Immunity Post-Autologous Transplantation in Multiple Myeloma;Transplantation and Cellular Therapy;2022-02

2. Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs;Frontiers in Immunology;2021-03-05

3. Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS;Leukemia;2020-01-03

4. Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma;Frontiers in Immunology;2019-01-21

5. Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy;Journal of Cancer Research and Clinical Oncology;2018-12-05